Novartis AG is 212.3x more valuable than SELLAS Life Sciences Group, Inc. by market capitalization ($283.13 B vs $1.33 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SLS | NVS |
|---|---|---|
| Market cap | $1.33 B | $283.13 B |
| US-listed rank | #2422 | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$26.86M | - |
| SEC filings | 1,262 | 947 |
Novartis AG is 212.3x more valuable than SELLAS Life Sciences Group, Inc. by market capitalization ($283.13 B vs $1.33 B).
Full pages: SELLAS Life Sciences Group, Inc. and Novartis AG, or browse the full rankings.